Phase 3 Randomized Double-Blind Placebo-Controlled Study of NRP104 in Children Aged 6-12 With ADHD

NCT00556296 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

297

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: NRP104
DRUG: NRP104
DRUG: NRp104
DRUG: Placebo

Sponsor

New River Pharmaceuticals

Collaborators

[object Object]